Infection with Herpesvirus hominis, often associated with oral ulceration, was found to be more frequent in patients with myeloproliferative and lymphoproliferative disorders than in normal populations or patients with other diseases. This increased frequency was not associated with any deficiency of the humoral antibody response, suggesting a possible impairment of cellmediated immunity. The otherwise untreatable oral lesions appeared to respond effectively to local irradiation.
lished and accepted technique. However, it does have an inherent disadvantage in that there is a wide variation in the individual patient's response to oxytocin. Refined infusion pumps are thus required (MacVicar and Howie, 1967; Francis, Turnbull, and Thomas, 1970) or, if the Syntocinon is given in dilute solution, manual adjustment of the drip rate is wasteful of valuable nursing time. Even with these techniques, there is still an induction failure rate, probably owing to failure of the uterus to respond satisfactorily to exogenous oxytocin in some instances (MacVicar, 1971 ).
In the series described, when a combined prostaglandin E2 and oxytocin infusion was administered the range of oxytocin escalation was about a quarter (24%) of that which was required when the drug was infused alone. Also, from the comparative results of the series, on average the prostaglandin component of the combined infusion was apparently equivalent to a constant base line infusion of 10 units of oxytocin in 500 ml of solution at about 41 drops a minute (55 mU/min). We suggest that the simultaneous combined regimen is acceptable and enables adequate uterine stimulation to be achieved with a greatly reduced range of oxytocin escalation. The reduction in the total amount of oxytocin infused will tend to minimize the antidiuretic effect which may possibly be associated with oxytocin infusion (Liggins, 1962) . Finally, the total duration of labour may also be reduced when the combined infusion is used.
There is accumulating evidence to suggest that prostaglandin and oxytocin are both involved in the normal physiological process of labour (Brummer, 1971; Gillespie, 1972;  Gillespie, Brummer, and Chard, 1972) . It remains to be evaluated whether this combined regimen will reduce further the dwindling proportion of patients in whom induction of labour by amniotomy and oxytocic infusion is unduly prolonged or is totally unsuccessful.
Introduction
The frequent occurrence of severe oral ulceration in patients suffering from various types of leukaemia and lymphoma prompted an investigation into the aetiology of the oral lesions. Clinical impressions suggested an herpetic origin and others have commented on the frequency of herpetic infections in patients with myeloproliferative and lymphoproliferative disorders (Stewart, 1950; Ultman et al., 1959; Muller et al., 1972) few patients, however, have been subjected to virological investigations. In the present study virological investigations hominis (herpes simplex virus) in the pathogenesis of the lesions observed. The study was further extended to determine the frequency of herpetic infection in patients with myeloproliferative and lymphoproliferative disorders, and to relate any increase to an abnormality of the humoral immune response.
Patients and Methods
A total of 69 patients attending a haematology clinic for a myeloproliferative or lymphoproliferative disorder, of whom 15 had developed oral ulcerative lesions, were investigated for evidence of infection with H. hominis. For the purpose of this investigation 579 hospital inpatients who had had throat swabs taken for virological investigation of respiratory infections between 1966 and 1970 served as control subjects.
TREATMENT
The drug regimens for the myeloproliferative and lymphoproliferative disorders were conventional dosages of appropriate combinations of the accepted antimitotic agents.
Oral and perioral lesions were treated by local irradiation using a 100 kV superficial therapy x-ray apparatus delivering incubation was taken to represent the neutralizing titre. To preserve low titre antibodies sera were not heat-inactivated Toniguchi, 1964, 1966; Heineman, 1967) (Table IV) . (Buddingh et al., 1953; Yoshino et al., 1962; Smith et al., 1967) . A four-fold rise in the level of serum antibody is characteristic of a primary infection but patients with recurrent herpetic infections usually exhibit a permanently high level of antibody (Scott et al., 1952; Scott, 1957) . Sera from various categories of patients and from control subjects were tested for neutralizing antibody to H. hominis, and the results are summarized in Table V . Sera from patients with viral or (Douglas and Couch, 1970; Lindgren et al., 1968 as most of the patients were receiving prophylactic or therapeutic doses of nystatin.
About half the patients in the series had received treatment with daunorubicin or cytarabine on at least one occasion. Both these cytotoxic drugs are known to inhibit herpesvirus replication (Cohen et al., 1969; Underwood, 1962; Underwood et al., 1964) , so that enhancement of herpetic infection in these patients is surprising, particularly as seven out of 18 patients who showed evidence of herpetic infection had received treatment with one of these drugs in the preceding month.
Cutaneous and perioral herpetic lesions have been successfully treated by local application of idoxuridine preparations (Muller et al., 1972; MacCallum, 1964, 1965) but the treatment requires frequent applications and is not generally applicable to intraoral lesions. Local irradiation proved to be a more practical and convenient method of treatment, which was very effective in promoting rapid healing of the otherwise intractable oral lesions. Its success may be due to direct inactivation of the virus, and it is of interest that virus was not recovered from the few swabs available after local irradiation.
Myeloproliferative and lymphoproliferative disorders are often associated with abnormalities of the immune response (Aisenberg, 1962; Miller, 1962) , and the high dosages of irradiation and many of the drugs that the present patients received are immunosuppressive. Although a relation between the high incidence of herpetic infection and some deficiency of the immune response was, therefore, possible our findings have failed to yield evidence of any gross deficiency in antibody production. Serological investigation differentiates between the two main types of herpetic infection; primary infections which occur in non-immunes, and recurrent infections which occur in those with persistently high levels of antibody. After primary infection, which may be clinical or subclinical and is usually acquired in childhood, the virus is believed to remain latent in the tissues (Burnet and Williams, 1939; Paine, 1964) . Reactivation of the virus in some patients from time to time leads to periodic recurrent infection. Since characteristically high levels of antibody were observed in acute phase sera from most of the present patients with clinical or virological evidence of infection, and no rise in titre was seen in sera from four out of six patients from whom serial specimens were available, the herpetic syndromes observed were presumed to be mainly of the recurrent type.
The failure of serum neutralizing antibody to affect the development of the herpetic lesions suggests that some deficiency of cell-mediated rather than humoral immunity is responsible for their frequent occurrence in these patients. Indeed, the results of Wilton et al. (1972) suggest that susceptibility to recurrent herpetic infection is related to impairment of lymphocyte activity (reflected by impaired inhibition of macrophage migration and lymphocyte cytotoxicity) rather than to any impairment of lymphocyte sensitization or antibody production. Moreover, recovery from herpetic infection is associated with delayed-type hypersensitivity to one of the soluble antigens of H. hominis (Nagler, 1944; Rose and Molloy, 1947) . The occurrence of severe herpetic lesions in the presence of adequate titres of circulating antibody in patients maintained on large doses of immunosuppressive agents after organ transplantation and in patients with Wiskott-Aldrich syndrome lends support to this hypothesis (Montgomerie et al., 1969; St. Geme et al., 1965) . Clearly, further investigations of cell-mediated immunity in patients with myeloproliferative and lymphoproliferative disorders are indicated.
In this report no attempt has been made to differentiate the effect of the disease from that of its treatment in contributing to the increased frequency of herpetic infections observed. Nor was it possible to do so, as herpetic infection usually occurred during or shortly after an active phase of the disease which necessitated treatment. It may be noted, however, that in the series of Hersh et al. (1965) 70%0 of patients with acute leukaemia died of infectious conditions whether they had received antimitotic therapy or not.
